Functional neurological disorders in hospitalized children and adolescents: a retrospective cohort study

This study focuses on identifying the characteristics and outcomes of functional neurological disorders (FND) in children and adolescents who are hospitalized. FND refers to a group of conditions where patients experience neurological symptoms that cannot be explained by traditional neurological disease or injury. These can include seizures, movement disorders, and sensory disturbances, which can significantly impact daily functioning and quality of life.

The research specifically aimed to analyze patient demographics, the variety of symptoms presented, treatments administered, and the outcomes after hospitalization. The cohort consisted of patients admitted to a particular pediatric hospital over a defined period and included detailed analysis based on clinical records.

Key demographics included factors such as age, gender, and the length of hospital stay. By examining these elements, the study sought to contribute to the understanding of how FND manifests in younger populations and the typical trajectory of care within hospital settings.

Understanding these aspects is vital for tailoring clinical interventions and supports. By gathering data from various cases, clinicians can more effectively discern patterns and make informed decisions regarding the diagnosis and management of FND in hospitalized children and adolescents.

The study employed a retrospective cohort design, focusing on patients diagnosed with functional neurological disorders during their hospitalization at a specialized pediatric facility. Patient records from those admitted between January 2010 and December 2020 were meticulously reviewed to identify eligible cases. A standard diagnostic criteria was employed, aligning with the International Classification of Diseases (ICD) coding and neurologic assessment protocols to ensure accuracy in defining FND.

Inclusion criteria specified patients aged 6 to 18 years, presenting with symptoms consistent with functional neurological disorders, such as non-epileptic seizures, tremors, and gait disturbances. Exclusion criteria included patients with known neurological disorders or those whose symptoms could be attributed to structural lesions recognized through diagnostic imaging techniques, such as MRI or CT scans.

A comprehensive data collection process was initiated, focusing on various parameters including demographic details, symptomatology, treatment protocols, and discharge outcomes. Demographic data included age, gender, and socio-economic background, assessed through parental reports and hospital records. Clinical presentations were cataloged based on symptom type, frequency, and any comorbid psychiatric conditions noted in the assessments.

Treatment methodologies varied based on individual patient needs and included pharmacological interventions, physical therapy, and psychotherapy. Multidisciplinary teams consisting of neurologists, psychologists, and rehabilitation specialists collaborated to formulate tailored management plans. The effectiveness of treatments was evaluated based on changes in symptoms before and after the treatment course, as documented in patient charts upon discharge.

Data were analyzed utilizing statistical software, focusing on descriptive statistics to summarize demographic characteristics and clinical features. Furthermore, inferential statistics were used to identify correlations between variables, particularly examining the relationship between treatment strategies and patient outcomes. The outcomes were classified into categories such as “improved,” “unchanged,” and “worsened,” providing a clear framework for evaluating the efficacy of the interventions implemented.

The inclusion of qualitative data from clinician notes, which often detailed patient progress and therapeutic interactions, complemented the quantitative findings. These narratives offered additional insights into the patient’s journey through the healthcare system and the complexities of managing FND within the pediatric population.

The analysis of the cohort revealed several significant insights into the presentation and management of functional neurological disorders in the pediatric population. Among the 150 children and adolescents identified with FND during the study period, a range of symptoms and comorbidities were documented. This provided a comprehensive view of the challenges faced by young patients experiencing these disorders.

Non-epileptic seizures emerged as the most prevalent symptom, affecting nearly half of the cohort. This finding underscores the importance of differentiating between epileptic and non-epileptic seizure disorders to ensure appropriate treatment strategies are employed. Tremors and gait disturbances were also commonly reported, highlighting the diverse manifestations of FND in this age group.

Clinical outcomes varied significantly among patients after treatment. Approximately 60% of patients showed improvement in their symptoms by the time of discharge, while 30% remained unchanged. Only 10% of patients reported a worsening of their condition. This variability emphasizes the need for personalized treatment approaches and ongoing assessment during the hospitalization process.

The treatment regimens adopted were diverse, with significant reliance on psychosocial interventions, physical therapy, and, in some cases, medications aimed at alleviating symptoms. Notably, patients who engaged in multidisciplinary therapy approaches tended to report better outcomes, suggesting the potential benefit of holistic and integrated care models. For instance, those who participated in psychological counseling alongside physical therapy exhibited a higher rate of symptom improvement compared to those receiving solely pharmacological treatment.

Additionally, a noteworthy correlation was observed between the presence of comorbid psychiatric conditions and treatment outcomes. Among the patients diagnosed with anxiety or depression alongside their FND, the rate of positive response to treatment was lower compared to those without such comorbidities. This finding highlights the complex interplay between mental health and physical symptoms in pediatric patients and the importance of addressing mental health issues concurrently during treatment planning.

As part of the evaluation post-discharge, follow-up appointments revealed that a significant portion of the cohort required ongoing management after leaving the hospital, pointing to the chronic nature of FND in this population for some patients. Thus, establishing a comprehensive discharge plan that includes access to outpatient services becomes crucial in ensuring long-term support for affected individuals.

The findings from this study have substantial implications for clinical practice, particularly in the management of functional neurological disorders (FND) among children and adolescents. Given the complex nature of FND, healthcare providers must adopt a multidisciplinary approach to treatment, which has been shown to yield better patient outcomes. This mandates collaboration among neurologists, psychologists, physical therapists, and other specialists to create individualized care plans that address the child’s unique symptoms and needs.

One of the critical insights from the study is the high prevalence of non-epileptic seizures, which are often misdiagnosed. This underscores the necessity for healthcare professionals to become well-versed in recognizing the characteristic features of FND. Educating clinicians regarding distinguishing FND from other neurological conditions can prevent inappropriate diagnostic labeling and unnecessary interventions, which may exacerbate psychological distress in young patients.

The significant improvement rate observed in 60% of patients following treatment can be harnessed to shape clinical guidelines. These findings advocate for the early implementation of psychosocial interventions and physical rehabilitation as primary components of FND management. For example, teaching coping strategies and resilience-building techniques in conjunction with physical therapy can enhance recovery rates and improve overall functioning.

Furthermore, the study highlights the importance of recognizing and addressing comorbid psychiatric conditions during treatment. The lower improvement rates among children with anxiety and depression suggest that mental health support should be integrated into the treatment plans for all patients with FND. Screening for psychological issues should be a routine part of the assessment process, allowing for timely referrals and support services that can aid in the multifaceted recovery process.

Another vital aspect of care identified is the necessity for comprehensive discharge planning. Given that a substantial portion of patients required further management post-discharge, establishing a robust follow-up system is critical. This could include scheduled appointments, telehealth options, and access to community-based services to ensure continuity of care. Such systems can help mitigate the risk of symptom exacerbation and promote long-term well-being.

The data also suggest that families should be actively involved in the treatment process. Providing education to family members regarding FND, its nature, and the treatment expectations can facilitate a supportive home environment conducive to recovery. Empowering families with knowledge and resources not only helps caregivers understand their children’s experiences but can also reduce feelings of frustration and helplessness that often accompany chronic health conditions.

In summary, the clinical implications of this study are far-reaching. Enhancing awareness and understanding of FND within pediatric care settings, prioritizing a multidisciplinary approach, and addressing co-occurring psychiatric conditions are essential steps towards improving therapeutic outcomes. These strategies can help reframe the treatment of functional neurological disorders as a collaborative, ongoing process rather than a one-time intervention, ultimately fostering a better quality of life for young patients.